Aperture-tuning antenna keeps 5G signals strong across wider frequencies
Peer-Reviewed Publication
Updates every hour. Last Updated: 29-Oct-2026 11:16 ET (29-Oct-2026 15:16 GMT/UTC)
A compact aperture-adjustable antenna developed by researchers at Science Tokyo could improve high-speed wireless communication across the wide 5G millimeter-wave frequency bands without increasing power consumption. The system maintained strong performance across 57–71 GHz band, improved signal strength by up to 62.2% at 57 GHz and 47.9% at 71 GHz, and achieved data transmission speeds of up to 56 Gb/s. These could support future Beyond 5G and 6G applications, including XR and data-intensive technologies.
Prior to 2021, poison control centers nationally received roughly 1,000 to 1,500 cases per year. After mid-2021, these volumes nearly doubled, and by 2023 poison centers logged more than 8,000 GLP-1RA-related calls.
Most cases stemmed from unintentional dosing or therapeutic errors rather than deliberate misuse, but the UT San Antonio researchers found the massive increase jarring nonetheless.
Christoph Bock, Principal Investigator at CeMM and Professor of Medical Informatics at the Medical University of Vienna, has been awarded an ERC Advanced Grant by the European Research Council (ERC). With €2.5 million in grant funding from the European Union, the Solid-CART project seeks to develop stronger and smarter CAR T cells as immunotherapy for solid tumors.
Thomas Pock, head of the Institute of Visual Computing at Graz University of Technology (TU Graz), has been awarded an Advanced Grant from the European Research Council (ERC) for his project EAGLE – Efficient Algorithms for Generative Learning. In his research, the computer scientist aims to develop novel generative learning methods and algorithms. He will receive funding of 2.5 million euros for this, with the project running for five years.
• Huntington’s disease is a genetic disorder that gradually destroys brain cells over the course of 10 to 30 years, typically starting between the ages of 35 and 50
• Phase 1b/2a will evaluate the safety of the treatment and provides hope for those with few options to slow the progression of the disease
• Clinical trial will enroll 21 people with early-stage Huntington’s disease, with 12 participants in a phase 1b dose-escalation group and nine in a phase 2a expansion group
While cryo-electron microscopy is a powerful method for determining the three-dimensional structure of proteins, preparing high-quality samples for it remains challenging.
The Papp Team at EMBL Grenoble has developed two prototypes to automate sample preparation and quality control: EasyGrid and EasyGrid Control, as described in a recent Nature Methods publication.
These unique instruments can be used across scales for cryo-electron microscopy and tomography, as well as X-ray nano-imaging.
EasyGrid Control will soon be offered as a service to the scientific community and prepared to be commercialised.